Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Hubner

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Medical Oncology|May 20, 2020
Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysisMairéad G McNamara, Melissa Frizziero, Timothy Jacobs, et al.
Clinical Science (London, England : 1979)|May 14, 2003
Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the ratEiji Kubota, Rachael G Dean, Richard A Hubner, et al.
Journal of Clinical Medicine|January 23, 2020
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated DiagnosisMelissa Frizziero, Bipasha Chakrabarty, Bence Nagy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 19, 2020
Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare?Zainul Abedin Kapacee, Mairéad G McNamara, Nicola de Liguori Carino, et al.
Cancers|April 12, 2022
Targeted Therapies for Perihilar CholangiocarcinomaSimon Gray, Angela Lamarca, Julien Edeline, et al.
Cancers|August 12, 2023
Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to KnowMatthew D Robinson, Mairéad G McNamara, Hamish W Clouston, et al.
Cancer Metastasis Reviews|December 17, 2016
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?Salvatore Galdy, Angela Lamarca, Mairéad G McNamara, et al.
British Journal of Cancer|October 19, 2021
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapyRoseanna C Wheatley, Elaine Kilgour, Timothy Jacobs, et al.
International Journal of Cancer|July 21, 2007
Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trialRichard A Hubner, Kenneth R Muir, Jo-Fen Liu, et al.
Cancer Treatment Reviews|January 28, 2020
Current standards and future perspectives in adjuvant treatment for biliary tract cancersAngela Lamarca, Julien Edeline, Mairéad G McNamara, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Medical Oncology|May 20, 2020
Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysisMairéad G McNamara, Melissa Frizziero, Timothy Jacobs, et al.
Clinical Science (London, England : 1979)|May 14, 2003
Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the ratEiji Kubota, Rachael G Dean, Richard A Hubner, et al.
Journal of Clinical Medicine|January 23, 2020
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated DiagnosisMelissa Frizziero, Bipasha Chakrabarty, Bence Nagy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 19, 2020
Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare?Zainul Abedin Kapacee, Mairéad G McNamara, Nicola de Liguori Carino, et al.
Cancers|April 12, 2022
Targeted Therapies for Perihilar CholangiocarcinomaSimon Gray, Angela Lamarca, Julien Edeline, et al.
Cancers|August 12, 2023
Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to KnowMatthew D Robinson, Mairéad G McNamara, Hamish W Clouston, et al.
Cancer Metastasis Reviews|December 17, 2016
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?Salvatore Galdy, Angela Lamarca, Mairéad G McNamara, et al.
British Journal of Cancer|October 19, 2021
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapyRoseanna C Wheatley, Elaine Kilgour, Timothy Jacobs, et al.
International Journal of Cancer|July 21, 2007
Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trialRichard A Hubner, Kenneth R Muir, Jo-Fen Liu, et al.
Cancer Treatment Reviews|January 28, 2020
Current standards and future perspectives in adjuvant treatment for biliary tract cancersAngela Lamarca, Julien Edeline, Mairéad G McNamara, et al.
Pageof 11